BIOTECH FIRM'S PROMISE STYMIED BY LACK OF FUNDS

BIOTECH FIRM'S PROMISE STYMIED BY LACK OF FUNDS

Seragen Inc., best known for the messy controversy over its relationship with Boston University and

You are only viewing part of an article, please register to get full access.